1. Home
  2. ARDX vs ADTN Comparison

ARDX vs ADTN Comparison

Compare ARDX & ADTN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ARDX
  • ADTN
  • Stock Information
  • Founded
  • ARDX 2007
  • ADTN 1985
  • Country
  • ARDX United States
  • ADTN United States
  • Employees
  • ARDX N/A
  • ADTN N/A
  • Industry
  • ARDX Biotechnology: Pharmaceutical Preparations
  • ADTN Telecommunications Equipment
  • Sector
  • ARDX Health Care
  • ADTN Telecommunications
  • Exchange
  • ARDX Nasdaq
  • ADTN Nasdaq
  • Market Cap
  • ARDX 882.9M
  • ADTN 708.5M
  • IPO Year
  • ARDX 2014
  • ADTN 1994
  • Fundamental
  • Price
  • ARDX $5.04
  • ADTN $9.05
  • Analyst Decision
  • ARDX Strong Buy
  • ADTN Strong Buy
  • Analyst Count
  • ARDX 9
  • ADTN 5
  • Target Price
  • ARDX $10.50
  • ADTN $12.80
  • AVG Volume (30 Days)
  • ARDX 3.2M
  • ADTN 1.4M
  • Earning Date
  • ARDX 10-30-2025
  • ADTN 11-03-2025
  • Dividend Yield
  • ARDX N/A
  • ADTN N/A
  • EPS Growth
  • ARDX N/A
  • ADTN N/A
  • EPS
  • ARDX N/A
  • ADTN N/A
  • Revenue
  • ARDX $386,146,000.00
  • ADTN $983,368,000.00
  • Revenue This Year
  • ARDX $17.34
  • ADTN $17.80
  • Revenue Next Year
  • ARDX $27.08
  • ADTN $8.37
  • P/E Ratio
  • ARDX N/A
  • ADTN N/A
  • Revenue Growth
  • ARDX 83.88
  • ADTN 3.52
  • 52 Week Low
  • ARDX $3.21
  • ADTN $6.02
  • 52 Week High
  • ARDX $6.78
  • ADTN $12.44
  • Technical
  • Relative Strength Index (RSI)
  • ARDX 33.54
  • ADTN 47.69
  • Support Level
  • ARDX $4.71
  • ADTN $8.40
  • Resistance Level
  • ARDX $5.27
  • ADTN $9.54
  • Average True Range (ATR)
  • ARDX 0.19
  • ADTN 0.32
  • MACD
  • ARDX -0.04
  • ADTN -0.01
  • Stochastic Oscillator
  • ARDX 30.80
  • ADTN 48.94

About ARDX Ardelyx Inc.

Ardelyx Inc is a biopharmaceutical company developing and commercialize, first-in-class medicines that meet unmet medical needs. It has developed a platform that enabled the discovery of new biological mechanisms and pathways to develop potent and efficacious therapies that minimize the side effects and drug-drug interactions frequently encountered with traditional, systemically absorbed medicines. It product Tenapanor, branded as IBSRELA, is used for the treatment of adults with IBS-C. Tenapanor, branded as XPHOZAH, is used to reduce serum phosphorus in adults with CKD on dialysis as add-on therapy in patients who have an inadequate response to phosphate binders or who are intolerant of any dose of phosphate binder therapy.

About ADTN ADTRAN Holdings Inc.

Adtran Holdings Inc is a provider of networking and communications platforms, software, and services focused on the broadband access market. It operates under two reportable segments: Network Solutions, which includes hardware and software products that enable a digital future that supports the company's Subscriber, Access & Aggregation, and Optical Networking Solutions; and Services & Support Segment which includes network design, implementation, maintenance and cloud-hosted services supporting the company's Subscriber, Access & Aggregation, and Optical Networking Solutions.

Share on Social Networks: